Author

Kailu Yang

Howard Hughes Medical InstituteORCID 0000-0002-8234-1997Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Axel T. BrüngeriD· 1 shared Chuchu WangiD· 1 shared Francesco TopiiD· 1 shared Giuseppe BalistreriiD· 1 shared John KuriyaniD· 1 shared Jussi HepojokiiD· 1 shared K. Ian WhiteiD· 1 shared Lauri KareineniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Axel T. BrüngerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Kailu Yang, Chuchu Wang, Francesco Topi, Serena Muratcioğlu, Ravi Kant, Tomas M. Strandin, Yih Tyng Bong, Lauri Kareinen, Sanna Mäki, Saber H. Saber, Tobias Binder, Tarja A. Sironen, Subu K. Subramanian, K. Ian White, Richard A. Pfuetzner, , Axel T. Brünger

This study designs and validates protease-resistant antiviral peptides that inhibit SARS-CoV-2 fusion, showing improved efficacy in vitro and in vivo.

bioRxiv · Nov 2, 2026 · PreprintMicrobiology